Cocrystal pharma to participate at the h.c. wainwright global investment conference

Bothell, wash., sept. 03, 2025 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) (“cocrystal” or the “company”) announces that james martin, cfo and co-ceo, will present a company overview at the h.c. wainwright 27th annual global investment conference on tuesday, september 9, 2025 at 12:00 p.m. eastern time.

COCP Ratings Summary

COCP Quant Ranking